panss

Symptoms , efficacy and security were rated with the PANSS and TESS .

以阳性与阴性症状量表（PANSS）及不良反应量表（TESS）评定症状、疗效和安全性。

Results At the end of 8th week , the scores of PANSS in both groups decreased significantly compared with pre-treatment ( P < 0.01 ), effective rates were 70.0 % in risperidone group and 71.4 % in perphenazine group , which showed no significant difference ( P > 0.05 );

结果治疗第8w末，两组阳性与阴性症状量表评分较治疗前均显著降低（P<0.01），研究组有效率70.0%，对照组71.4%，两组疗效差异无显著性（P>0.05）；

The differences of PANSS reduction between the two groups was not significant .

2组PANSS评分及减分无差异。

The Chinese Norm and Factor Analysis of PANSS

阳性和阴性症状量表的中国常模和因子分析

The comparative validity and inner reliability of PANSS were acceptable .

PANSS的平行效度和内部一致性尚可。

A preliminary study of efficacy of risperidone on treating schizophrenia and clinical application of PANSS

维思通治疗精神分裂症疗效与PANSS应用的初步研究

Objective To explore the application of the PANSS in the criminals with schizophrenia .

目的探讨阳性与阴性症状评定量表在精神分裂症罪犯中的应用现状。

Psychiatric symptoms were assessed by Positive and Negative Syndrome Scale ( PANSS ) .

并用阳性和阴性症状量表（PANSS）评定患者的精神症状。

The PANSS score of negative symptoms of the short-term group was significantly lower than the long-term group .

短期住院组较长期住院组，患者回家意愿强，阴性症状少；

Results The PANSS scores in both groups decreased significantly after treatment ( P < 0.05 or 0.01 ) .

结果两组治疗后阳性和阴性症状量表评分与治疗前比较均有显著下降，差异均显著或极显著性（P<0.05或0.01）。

The positive and negative symptoms were measured with the PANSS and SANS .

同时，对病人进行阳性和阴性症状评定量表（PANSS）测查。

Positive and negative symptoms scale ( PANSS ) were used to evaluate the severity of the symptoms .

用阳性与阴性症状量表（PANSS）于治疗前后对症状严重程度进行评定。

Total score of educational level , negative symptoms , the score of PANSS has significant correlation with cognitive function .

受教育程度、阴性症状和PANSS总分与认知功能有显著的相关性。

Results : The scores of PANSS of both groups before and after treatment were significant difference ( P < 0.01 ) .

结果：两组PANSS分值治疗前后差异均有显著性（P<0.01）；

Results : PANSS scale in endpoint was decreased significantly than baseline in both groups ( P < 0.01 ) .

结果两组PANSS评分较治疗前均有显著下降（P均<0.01）；

Scores of positive factors of PANSS correlated positively with pretreatment serum IL 6 level but not TNF α .

治疗前血清IL－6水平与PANSS阳性因子分显著正相关，而血清TNF－α与PANSS总分无相关。

The quality of life and curative effect 's were assessed with the GQOLI-74 and PANSS before and after treatment respectively .

应用阳性与阴性症状量表（PANSS）、生活质量综合评定问卷（GQOLI-74）分别于治疗前后评估患者的生活质量与疗效。

Results Responses showed in 3 month after treatment . PANSS score was significantly lower than that of before operation and got effect peak in one year .

结果伽玛刀术后三月开始起效，PANSS评分显著降低，以后一直平稳维持。

The indexes of false memory had no significant correlation to the factors of delusion and hallucination of PANSS .

精神分裂症患者的虚假记忆指标与PANSS总分、阴性症状、阳性症状以及妄想症状、幻觉症状无显著相关性。

Result : Thinking disorder factor and active factor of BPRS and P value of PANSS affect the competency to stand trial significantly ;

结果：BPRS的思维障碍因子、激活性因子、PANSS的P分对受审能力具有显著影响；

Study on Personality Disorder and Coping Style Among Male Adult Criminals The PANSS on probation in the criminals with schizophrenia

成年男性罪犯的人格障碍及应对方式PANSS在罹患精神分裂症罪犯中的试用

Brief psychiatric Rating Scale ( BPRS ) and Positive And Negative Syndrome Scale ( PANSS ) were used to assess the effects .

采用简明精神病量表（BPRS）、阳性和阴性症状量表（PANSS）进行评价。

Results : After 8.12 week treatment , the total scores of PANSS and negative symptom scale were significantly different between two groups ( P < 0.05 ) .

结果治疗后8、12周，两组PANSS总分、阴性因子分比较差异有统计学意义（P<0.05）。

Result There was significant differences on PANSS between pre-and post-treatment , but not on any group of2,4,8 week .

结果PANSS疗前与疗后评分均有显著性差异，疗后2、4、8周各项两组间比较均没显著性差异；

Preliminary results showed a significant improvement on the PANSS scale of12 cf7 on iloperidone or placebo , respectively .

伊潘立酮或安慰剂在阴性与阴性症状量表范刻度7与12时，初始结果分别显示出明显提高。

Methods Control studies of loxapine succinate and clozapine were conducted , and curative effects and side effects were evaluated with PANSS and TESS .

方法应用丁二酸洛沙平与氯氮平进行对照治疗研究，采用PANSS、TESS评定疗效及副反应。

The positive and negative syndrome scale ( PANSS ) and treatment emergent symptoms scale ( TESS ) were used to evaluate curative effect and untoward reaction .

采用阳性症状和阴性症状量表（PANSS）评定临床疗效，不良反应量表（TESS）评定不良反应。

Methods : PANSS was administered to 190 schizophrenic patients of different subtypes and courses of illness , sampled from 11 psychiatric institutions in China .

为在中国精神分裂症病人中的应用提供参数。方法：在全国11个精神卫生机构对不同病程和亚型的精神分裂症病人进行PANSS评定。

Compared with baseline , the scores of PANSS and BPRS in endpoint were significantly reduced in both groups ( P < 0.05 ) .

治疗结束时，2组PANSS和BPRS评分较入组时均显著减低（P＜0.05）；

Quetiapine treated patients demonstrated significantly decrease in PANSS negative factor , cognitive factor , PANSS total scale than chlorpromazine-treated patients ( P < 0.01 ) .

在阴性因子、认知因子、PANSS总分减分率方面，奎硫平组与氯丙嗪组有显著性差异（P<0.01）。